Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Yung

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomasV A Levin, W K A Yung, J Bruner, et al.
Clinical Radiology|April 2, 2022
The ins and outs of male breast and anterior chest wall lesions from childhood to adulthoodS Yang, Y Leng, C M Chau, et al.
Journal of Neuro-Oncology|June 27, 2008
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastomaJ F de Groot, M R Gilbert, K Aldape, et al.
Molecular Psychiatry|July 13, 2016
Lithium suppression of tau induces brain iron accumulation and neurodegenerationP Lei, S Ayton, A T Appukuttan, et al.
Neuro-Oncology|March 15, 2006
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, Kathleen Lamborn, W K A Yung, et al.
Cell Reports|November 30, 2017
Testosterone Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway InflammationJacqueline-Yvonne Cephus, Matthew T Stier, Hubaida Fuseini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with afliberceptJohn F de Groot, Yuji Piao, Hai Tran, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 2021
Prognostic Significance of IDH1/2 Mutation and MGMT Promoter Methylation Status in RTOG 9813J L Fleming, S Pugh, E H Bell, et al.
Neuro-Oncology|February 11, 2004
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, W K A Yung, Kurt A Jaeckle, et al.
Schizophrenia Research|October 23, 2017
The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quoM J McHugh, P D McGorry, H P Yuen, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomasV A Levin, W K A Yung, J Bruner, et al.
Clinical Radiology|April 2, 2022
The ins and outs of male breast and anterior chest wall lesions from childhood to adulthoodS Yang, Y Leng, C M Chau, et al.
Journal of Neuro-Oncology|June 27, 2008
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastomaJ F de Groot, M R Gilbert, K Aldape, et al.
Molecular Psychiatry|July 13, 2016
Lithium suppression of tau induces brain iron accumulation and neurodegenerationP Lei, S Ayton, A T Appukuttan, et al.
Neuro-Oncology|March 15, 2006
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, Kathleen Lamborn, W K A Yung, et al.
Cell Reports|November 30, 2017
Testosterone Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway InflammationJacqueline-Yvonne Cephus, Matthew T Stier, Hubaida Fuseini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with afliberceptJohn F de Groot, Yuji Piao, Hai Tran, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 2021
Prognostic Significance of IDH1/2 Mutation and MGMT Promoter Methylation Status in RTOG 9813J L Fleming, S Pugh, E H Bell, et al.
Neuro-Oncology|February 11, 2004
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, W K A Yung, Kurt A Jaeckle, et al.
Schizophrenia Research|October 23, 2017
The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quoM J McHugh, P D McGorry, H P Yuen, et al.
Pageof 9